Atrial Fibrillation Trial, Recruiting NCT07641582 Sponsor: Seoul St. Mary's Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07641582
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have symptoms that could suggest an irregular heartbeat that comes and goes, such as occasional fluttering in the chest or chest discomfort
  • People aged 60 or older who have no symptoms but have at least one of the following health conditions or risk factors: high blood pressure, diabetes, coronary artery disease, heart valve problems, a weakened or enlarged heart, sleep apnea, an overactive thyroid, obesity (a BMI over 30), or regularly drinking alcohol more than 3 times per week

Who may not be able to join:

  • People younger than 20 years old or older than 80 years old
  • People who have moderate or severe problems with memory or thinking
  • People who have already been diagnosed with atrial fibrillation (an irregular heartbeat condition) before the study begins
  • People who do not agree to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Young Choi, MD, PhD, The Catholic University of Korea

Phone: 82-2-1588-1511

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Seoul St. Mary's Hospital
Registry
ClinicalTrials.gov
Start date
19 November 2024
Est. completion
30 December 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Incidence of newly diagnosed atrial fibrillation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov